"You will be hard-pressed to find much helpful information about these two drugs in the mainstream, though. Because they are off-patent, ivermectin and fenbendazole bring in minimal profits, which means pharmaceutical companies are not interested in promoting them or touting their benefits." — 2nd Smartest Guy in the World
As a combination therapy these two drugs offer a highly synergistic approach to curing a wide range of ailments from slow kill bioweapon injection damage to prior-based diseases to (turbo) cancers, etc.
Resource Categories: Articles, COVID

Leave a Reply